Stephen S. Roberts

Hematology | Oncology
3181 SW Sam Jackson Park Rd
Portland, OR 97239

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

A Human Stem Cell Model of Neuroblastoma Identifies Four Chromosome 17q Genes that Drive Tumor Initiation and Progression.

A Human Stem Cell Model of Neuroblastoma Identifies Four Chromosome 17q Genes that Drive Tumor Initiation and Progression.

Journal: Cancer letters
Published: April 23, 2026

A functional landscape for chromosome 17q in neuroblastoma: balancing replication stress and genomic stability.

A functional landscape for chromosome 17q in neuroblastoma: balancing replication stress and genomic stability.

Journal: British journal of cancer
Published: December 05, 2025

A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remission.

A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remission.

Journal: International journal of cancer
Published: October 03, 2025

Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trial.

Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trial.

Journal: Journal of hematology & oncology
Published: September 22, 2025

Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma.

Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma.

Journal: Nature genetics
Published: August 06, 2025

A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission.

A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2024

NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors.

NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors.

Journal: Cell reports
Published: February 01, 2024

Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults.

Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults.

Journal: JCO precision oncology
Published: August 10, 2023

Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy.

Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy.

Journal: International journal of cancer
Published: June 06, 2023

Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.

Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.

Journal: JAMA oncology
Published: December 22, 2022

Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma.

Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma.

Journal: iScience
Published: December 20, 2022

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.

Journal: Frontiers in oncology
Published: November 23, 2022
Showing 1-12 of 62

Last Updated: 09/26/2026